Tyrosinase is the principal enzyme in the biosynthesis of melanin. The expression of tyrosinase is tissue-specific and appears to be regulated by various hormonal and environmental factors. Elucidation of the genomic structure and molecular basis of control of tyrosinase gene expression will greatly enhance our understanding of the regulation of human pigmentation. To this end, we have isolated and performed restriction mapping of recombinant cosmid and lambda phage clones containing the human tyrosinase gene, sequenced a 2.2-kilobase (kb) region of its promoter, and determined the potential regions regulating the tyrosinase gene expression in transient-expression system. The human tyrosinase gene is comprised of five exons and four introns. Based on our restriction mapping studies, the gene spans a distance of over 65-kb on chromosome 11 (q14 -q21). We constructed a series of plasmids (pHTY -CAT) that contain 5' sequential deletions of the human tyrosinase 5' flanking sequence fused to the reporter gene, chloramphenicol acetyl-T yrosinase (monophenol monooxygenase; monophenol, L-dopa: oxygen oxidoreductase, E.C. 1.14.18.1) is the core enzyme in melanogenesis, and is expressed in a tissue-specific manner among pigment cells [1, 2] . Previously, we isolated and characterized a human tyrosinase cDNA [3] , and mapped its chromosomal location to the q arm of chromosome 11 [4] . Subsequently, we and several other laboratories reported the human and mouse tyrosinase cDNA sequences [5 -8] . The gene encoding tyrosinase in humans comprises five exons, and a partial characterization of this gene has also been reported [9] .
Our earlier observations in the mouse indicated that the gene for tyrosinase is encoded by the genetically well-characterized c locus [3, 10] . This encoding has been demonstrated by the rescue of a c locus mutant-albino through the introduction of functional tyrosinase minigene constructs into mice [11, 12] . We showed that 2.1 kb of the 5' flanking sequence was sufficient to provide appropriate developmental regulation of tyrosinase gene expression, including induction of pigmentation in the retinal pigment epithelial cells [13] . Kluppel et af [14] have also indicated that melanocyte-specific expression of the tyrosinase gene in mice could be obtained with as little as 270 base pairs (bp) of 5' fiallking sequence, thereby suggest-Manuscript received September 1, 1993 ; accepted for publication January 10, 1994. Reprint requests to: Byoung S. Kwon transferase (CAT). The plasmids were used to locate promoter regions that are potential regulators of tyrosinase gene expression in a transient expression system using melanoma cell lines. In human melanoma cells, the plasmid construct with a -2020 base pair (bp) promoter yielded the highest CAT activity. When the deletions reached -1739 bp, the CAT activity was dramatically reduced, indicating that important enhancer elements for transcription control are present between -1739 and -2020 bp. Further deletions up to -550 bp also resulted in dramatic decreases of CAT activity. However, when the deletion included -550 bp of the 5' flanking sequence, there was 26 percent of the CAT activity compared to that of the -2020 bp promoter. Deletions beyond -550 bp also showed markedly decreased CAT activity. Based on our data, we suggest that human tyrosinase gene expression is governed by both tissue-specific and multiple regulatory elements. ] Invest Dermato11 02: [744] [745] [746] [747] [748] 1994 ing that cis-acting elements determining the expression of the mouse tyrosinase gene should lie within the small promoter region. On the contrary, in humans, this important information 011 the transcriptional control region is yet to be established. We and others have earlier reported the molecular basis of tyrosinase-negative oculocutaneous albinism in humans that causes a defect in melanin biosynthesis [15 -18] . The mutations observed so far were found to be associated only with the coding region of the tyrosinase gene. Elucidation of the detailed organization of the promoter region could also help to identify any molecular defects that affect transcriptional control of the tyrosinase gene. Analysis of promoter function becomes essential to identify cis-acting elements and trallSacting factors that direct tissue-specific and developmentally controlled expression of the human tyrosinase gene. These analyses are key to the understanding of the regulation of human pigmentation and certain forms of pigmentation disorders such as human hypopigmentation and albinism.
In this context, we have constructed a partial restriction map of the entire human tyrosinase gene including the promoter region, determined the sequence of the 2.2-kb promoter region, identified the transcription start sites, and characterized promoter functions in a transient expression system. Hybridizations were carried out overnight in a solution containing 6 X SSC, 5 X Denhardt reagent, 0.5% sodium dodecylsulfate, 100 Jlg/ml denatured fragmented salmon sperm DNA, and 1 X 10 6 epm probe/ml solution . The filters were washed in solution containi.ng 0 .1 X SSC and 0.5% sodium dodecylsulfate rwo degrees below the hybndization temperature, and exposed to the X-ray fi lm (X-OMA T, Kodak). The relative mobilities of the hybridized bands were determined and a restriction map of the human tyrosinase gene was constructed.
MATERIALS AND METHODS
Promoter Sequencing A 6-kb Bgl II fragment containing the 5' flanking region and the first exon from pCos 28A was subcloned in the pGEM3 (Promega, Madison, WI) vector. The 6-kb fragment also contained rwo EeoR I sites that were exploited for generating fragments of smaller length . Each smaller EcoR I fragment was subcloned in the pGEM 7 vector (Promega, Madison, WI). The nucleotide sequence of the 2.2-kb 5' flanking region from the A TG codon was determined by dideoxy chain termination sequencing using Sequenase (United States Biochemical Corporation, OH). T7 and SP6 primers and rwo other synthetic oligonucleotide primers, each of 16-bp lengths, corresponding to the antisense strand of the human tyrosinase gene were used for sequencing. The sequences of the primers used were 1) 5 / -GCTGTAGCCATATTGT-3' and 2) 5 / -TGGTGGGCTGA-TATTA-3 / , located at -963 and -1254 bases, respectively, upstream of the A TG codon of the human tyrosinase gene.
Sequence Analysis Computer analysis of the 2.2-kb 5' flanking sequence of the promoter was performed using the Pustell sequence analysis program (IBI, New Haven, CT) for homology search with reported sequences of different cis-acting clements involved in transcription regulation. The human tyrosinase sequence was also compared with 5' flanking sequences of mouse promoters, using the sequence-match program.
Primer Extension Analysis Two micrograms of poly(A)+ RNA from
Genovese melanoma cells were annealed with 5 X 10 5 cpm of kinased oligonucleotide primer at 20 · C ovemight in a buffer containing 0.4 M NaCl, 40 mM PIPES (pH 7.0) , 1 mM ethylenediamine tetraacetic acid (pH 8.0), and BO% formamide. The primer was a 17 mer corresponding to the antisense strand of the human tyrosinase gene with the sequence 5'-GAAATGGCCAGGGGAGG-3' located 44 bp downstream of the ATG codon. The mixture was precipitated with ethanol and suspended in reaction buffer containing 50 mM Tris-Cl (pH 7.6), 60 mM KCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 1 mM each dATP, dCTP, dGTP and dTTP, 1000 U/ml RNAsin (Promega Biotech, Madison, WI), and 50 U AMV reverse transcriptase (BRL Gaithersburg, MD). The extension reaction was performed at 37 · C for 2 h followed by the addition of 50 Jlg/ml RNase, and incubation for a?~ther 30 . min. The DNA was extracted with phenol-chloroform and precipitated With ethanol. The precipitate was dissolved in formamide buffer, heat-denatured, and analyzed on a sequencing gel. determined by dideoxy sequencing of each clone using a pCAT plasmid primer.
Transfection and Enzyme Assays pHTY -CAT plasmids were transfected into HeLa cells by the diethylaminoethyl (DEAE)-dextran method [19] and into melanoma cells, by electroporation [20] . For DEAE dextran transfection, cells were grown to a density of 0.5 X 10 6 cell s/100 mm culture dish . Prior to the addition of DNA in DEAE-dextran, cells were washed in Dulbecco's modified Eagle's medium without serum, followed by the addition of 4 ml Dulbecco's modified Eagle's medium with 10% feta l bovine serum. Twenty micrograms of cesium chloride-purified pHTY -CAT plasmid DNA and 2 J.lg of CMV -p-galactosidase (p-gal) internal-control plasmid were dissolved in 40 J.lI Tris-buffered saline (25 mM Tris, 135 mM NaCI, and 2.5 mM KCl) and mixed with 80 J.lI sterile 10 mg/ml DEAEdextran solution (Pharmacia). The DNA in DEAE-dextran sol ution was slowly spread on HeLa cells in Dulbecco's modified Eagle's medium, swirled gently, and incubated for 4 h at 37 "C. The medium with DEAE-dextran was removed from the dishes and a 10% dimethylsulfoxide (DMSO) in phosphate-buffered saline (pH 7.4, PBS) shock was given for 1 min. The DMSO was removed immediately with excess PBS. The cells were then subjected to chloroquine (0.1 mM in DMEM) treatment for 90 min and later grown in fre sh DMEM with fetal bovine serum at 37"C for 60 h~efore harvesting. For transfection by electroporation, cells were harvested from culture dishes and resuspended in FlO medium at a concentration of2 X 10 6 cells/ m!. For each transfection, 1 X 10 6 cells were aliquoted to individual cuvettes, 20 J.lg of pHTY -CAT plasmid, and 2 J.lg of p-gal internal-control plasmid were added and chill ed on icc for 10 min. Electroporation was carried out at 380 volts and 980 J.lF capacitance using a Progenitor II pulsar THE JOURNAL OF INVESTIGATIVE DERMATOLOGY (Hoefer Scientific) . Cells were then incubated on ice for 10 min, transferred to culture dishes with 10 ml of medium, and grown at 37 "C for 60 h prior to harvesting.
Cells were harvested by scraping and were washed two times with PBS. The cell pellets were suspended in 100 J.ll 0.25 M Tris, pH 8.0, and lysed by three cycles of freeze-thawing. Cell extracts were collected after centrifugation at 12,000 rpm for 10 min at 4 "C. Activities of p-gal and CAT were determined following standard methods [21] . Volumes of cell extract used for CAT assay were normalized based on p-gal activities in each sample. All transfections and enzyme assays were performed in duplicate.
RESULTS
Structure of the HUIllan Tyrosinase Gene Using the human tyrosinase eDNA probe Pmel 34, we isolated two independent recombinant cosmid clones and three lambda phage clones that contained portions of the human tyrosinase gene. Our restriction analysis data on four of the five clones indicated overlap of the regions between clones pATY3 and pATYIII, pATYIII and pATYIV, pATYIV and pCosTYV, which enabled us to costruct the map of the human tyrosinase gene. The gene spans a distance of approximately 65 kb. The clone pCos28A contained a 6-kb promoter region, first and second exons, first intron, and a 10-kb region of the second intron. Clones pATYIII, pATYIV, and pCosTYV contained the third, fourth, and fifth exons, respectively. The distances between each exon and the positions of the restriction sites on the human tyrosinase gene, based on our mapping strategy, are indicated in Fig 1. The intervening sequence (IVS) 1 spans a distance of approximately 22 kb. Our restriction-mapping data did not give an overlap of pCos28A, which contains the first and second exons with that of either pATY3 or pATYIII, which contained the third exon regions; hence, we could not determine precisely the length ofIvS 2. Nevertheless, our results clearly indicate the IVS 2 to be the largest intron, with a length of more than 26 kb. IVS 3 and IVS 4 were found to be approximately 10 kb and 9 kb, respectively. The clone pCosV also contained a 13-kb portion of the 3' flanking region of exon 5.
Identification of the Transcription Start Site
To determine the transcription initiation site, a 17 -base -long synthetic oligomer complementary to the non-coding strand was end-labeled, hybridized with poly(A)+ RNA isolated from Genovese cells, and extended with reverse transcriptase. The extension product was analyzed on a sequencing gel and the precise size of the transcripts determined by comparison to a corresponding genomic DNA sequence ladder generated alongside, using the same primer employed for primer extension. The results of the primer extension analysis indicated a m~or transcription start site situated 42 bases upstream from the ATG codon, and three minor transcription start sites at 34, 78, and 79 bases upstream of ATG. Three of these four sites started at A preceded by C (Fig 2) .
5' Flanking Sequence Analysis
To characterize the promoter region of the human tyrosinase gene, the nucleotide sequence of2.2 kb of the 5' flanking region subcloned in pGEM vector was determined (Fig 3) . Sequence analysis of the promoter indicated the presence of initiator and enhancer sequences. A TAT A box was identified at -27 bp upstream from the transcription start site, and a CAA T box was found at -128 bp upstream. In addition to these, there were also five putative AP-1, two AP-2, two glucocorticoidresponsive elements (GRE) , three Oct-1, and two UV-responsive elements found at different regions of the human tyrosinase promoter. Apart from these transcription regulatory elements, there was also a unique 230-base -long purine-rich domain present at -634 bases upstream from the transcription start site.
Functional Analysis of the Tyrosinase ProIlloter Our earlier experiments on the mouse tyrosinase gene promoter indicated that a 2.1 -kb portion of the promoter. was sufficient for producing pigmentation in transgenic mice [13] . With this observation ill mind, we studied the promoter function of a 2.02-kb 5' flanking region of the human tyrosinase gene in a transient expression system. To determine the promoter region that controls the human tyrosinase gene expression, a series of 5' deletion mutants of the 2.02-kb pro- . .
-1128 ATACTACTCATTTGAAAACTAACATAGTTAAGTTGTATTTTTAGCCATGA AGGAAG~CTCCTGGCTGTTTTGTACTGCCTGCTGTGGAGTTTCCAGA -1078 ATTTCAGTTTCCCTAGCTCACTATACACAGAGAAGGAAACTTTTGAAATA CCTCCGCTGGCCATTTCCCTAGAGCCTGTGTCTCCTCTAAGAACCTGAT mater was generated. The deleted constructs fused upstream to the CAT gene of a reporter plasmid were transfected into melanoma cells for the transient expression analysis.
Results of the CAT assays in human melanoma cells indicated t hat the highest activity was produced with the pHTY-CAT plasmid containing the entire -2020 bp region of the human tyrosinase promoter. All other CAT activities are e~pressed as percentages of this value. Deletion of the promoter regIOn upstream to -1739 bp rapidly decreased the CAT activity, indicating that important enhancer elements were present between -1739 and -2020 bp upstream. When the deletion reached -550 bp, there was 26 percent of CAT activity compared to that of -2020 bp construct. Further deletions covering -488, -258, and -83 bp of the promoter region also showed markedly decreased CAT activity, i.e., less than 2% of the -2020 bp fragment (Fig 4) .
DISCUSSION
We mapped the gene for human tyrosinase to chromosome 11 q 14-q21 [4] . In the present investigation, we have i~olated r~combinant cos mid and lambda phage clones that contamed regIOns of the human tyrosinase gene and we have performed restriction mapping of the entire human tyrosinase gene. The entire gene was found to encompass a distance of approximately 65 kb from the transcription start site to exon 5 (Fig 1) . The IVS 1 and 2 are longer than IVS 3 and 4. The sequence of the coding region of the human tyrosinase gene has already been determined by us and others [3, 6, 8] . Primer extension analysis indicated a major transcription start site at 42 bases upstream of the ATG codon. Apart from this, there were also three minor transcription initiation sites at regions 34, 78, and 79 bases upstream from the A TG codon. The transcription initiation sites at -42 and -79 bases upstream of ATG were reported earlier by Kikuchi et at [22] and differs from the earlier reports of T akeda et at [23] and Giebel et at [9] . The transcription initiation sites of our investigation started with an A preceded by C , as is commonly observed in other eukaryotic genes [24] . The discrepancies in the mRNA start site determination could also be due to the different cell lines used in each study. Similar differences in transcriptional start sites were also observed in the mouse tyrosinase gene with different pigment cell lines [11, 25] .
Earlier works on human tyrosinase gene promoter [9 ,22] have analyzed the nucleotide sequence of up to 1 kb region upstream of the transcription start site. To understand the promoter function in detail with regard to the control elements involved in human tyrosinase ge ne expression, we sequenced 2.2-kb tyrosi nase gene promoter region. Analysis of the nucleotide sequences of the 5' flarlking region of the human tyrosinase gene indicated the presence of several transc:iption initiatior and enhancer elements. The most common motifs, TATA box and CCAAT, were found at regions -27 and -128 bp upstream of the transcription initiation site, respectively. Apart fro m this, there was a core AP-l site w ith the sequence TGAGCTCA [26] found at -1297 bases upstream and four other close-consensus sequences for AP-l were found at regions -103, -971, -11 35, and -1 673 bases upstream of the transcription initiation site. Two close-consensus sequences for AP-2 element [27] were found far upstream from the initiation site at -1856 and -1865 bp. Sequences similar to the glucocorticoid-responsive element [28] were found at -1379 and -1679 bases upstream. Oct-1, ~n apparently ubiquitous element in most mammalian cells [29] was found at three regions -293 , -1209, and -1737 bases upstream . Sequences resembling the core UV -responsive element [30] were found at -1216 and -1894 bases upstream. The presence of various cis-acting elements in the promoter region of the human tyrosinase gene probably indicate that tyrosinase gene transcription is mediated by multiple regulatory elements. We further investigated the promoter functio n of the human tyrosinase gene using a transient ex pression system to define the areas of the 5' flanking region that playa vital role in transcriptional regulation. Maximal CAT activity was found il,1 the plasmid construct containing the entire 2.02-kb promoter region and 26% of CAT activity of the 2.02-kb promoter was observed in a construct bearing 0.55-kb of the promoter. Constructs bearing 1.73 kb and 1.17 kb, as well as those havi ng 0.43 and 0.25 kb regions of the promoter, produced less than 2 percent of the va lue of2.02 kb ( Fig  4) . This observation indicates that a potentially-important region for human tyrosinase gene expression should lie beyond 1.73 kb upstream of the transcription start site. This observation is similar to that of Shibata et at [31] w ho have also identified the presence of an important re gion in human tyrosinase promoter between -1. 8 kb and -2 kb upstream of transcription site. Though the presence of transcription initiator elements such as TAT A and CAA T sequences are contained within the first 150-bp region, it appears that they may not be adequate in controlling tyrosinase gene expression. We have also perfor.med similar transient transfection experiments with the pHTY -CAT constructs on HeLa cells and we observed no activity in any of them, including the longest 2.02-kb promoter. However, the reference plasmid that we used, pCAT -control plasmid with SV40 promoter and enhancer, showed equally efficient CAT activity in both melanoma and HeLa cells (data not shown). This observation also indicates the tissue-specific expression of the tyrosinase gene promoter. The presence of other ubiquitous cisacting elements in the promoter of the tyrosinase gene also suggests their interactions with probable tissue-specific elements in determining the transcription regulation. This could also be a factor in the observation of 26% reporter gene activity in plasmid constructs bearing 0.55 kb of the promoter. Our initial observation of the transcription-controlling regions of the human tyrosinase gene lends insight and impetus to further explorations for the precise determination of the nature of cis-acting sequences and trans-acting factors involved in human tyrosinase gene expression. Moreover, the information that a 2.02-kb region of the human tyrosinase gene promoter to be functionally effective in its transcription regulation could form a basis for future work in areas of gene transfer, since tyrosinase gene expression is melanocyte-specific.
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